Non-invasive prenatal diagnosis, called Prenatal Test or NIPT (Non Invasive Prenatal Test), allows to carry out the screening of the main fetal chromosomal abnormalities in pregnancy. A simple maternal blood sample is enough for the study of circulating fetal free DNA of the main fetal chromosomal abnormalities in pregnancy. A simple maternal blood sample is enough for the study of circulating fetal free DNA (cffDNA). Thanks to this investigation it is possible to identify, in addition to fetal sex, the most common aneuploidies of the fetus.
This is a quick, safe and reliable analysis that can be performed starting from the tenth week of gestation, even in the case of twin pregnancy and medically assisted procreation. The test result will be available within 7 working days.
At the U.O.C. Medical Genetics Laboratory of the San Camillo-Forlanini Hospital in Rome, the analysis for non-invasive prenatal diagnosis is complied with in accordance with the guidelines issued by the Ministry of Health and the Superior Health Council. The technological update carried out by the structure made it possible to implement the service offered to users by increasing the efficiency of the test. The sampling is preceded by a consultation with a specialist in Medical Genetics, who will provide the couple with the necessary information to be able to make a conscious, autonomous and informed choice.
In the event of a positive result (eg high risk for Trisomy 21), the woman and the couple will be taken care of by a multidisciplinary team including gynecologist, geneticist, pediatrician and other specialists. The invasive prenatal investigation (amniocentesis) to confirm the result, can then be carried out at the San Camillo-Forlanini Hospital in Rome and will be fully covered by the Regional Health System.
Contact the numberfrom mondy to friday 9.00-12.00